Company intelligence / Profile preview

BioScience Communications

New York City, New York, United Statesbioscicom.net ↗

Ownership: Private
Employees: ~68
Development stage: Other

Overview

BioScience Communications is a leading provider of medical and scientific communications services for biopharma, medical device, and emerging science companies. The firm specializes in science writing, strategic counsel, data visualization, digital strategy/solutions, and regulatory-compliant content development. It helps clients articulate complex scientific narratives to professional audiences across traditional and digital media channels. Founded in 1995 and based in New York City, it operates as the global medical communications division of Edelman.

Industry: Consulting

Beyond the preview

Go deeper on BioScience Communications.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioScience Communications.

Explore the full profile